State Action
CCAGW Urges Nevada Senate to Oppose SB 509
SB 509 would grant $380 million in public subsidies and tax breaks for the construction of a stadium for the Oakland Athletics in Las Vegas.
CCAGW Urges Maine Joint Judiciary Committee to Oppose LD 1973
LD 1973 will fail to achieve its objective of protecting consumer privacy.
CCAGW Urges Louisiana Senate Health and Welfare Committee to Oppose HB548
HB548 will make changes to the federal 340B drug discount program.
CCAGW Urges North Carolina Senate Health Care Committee to Oppose HB 246
HB 246 would impose onerous regulations on pharmacy benefit managers.
CCAGW Urges North Carolina Senate Commerce and Insurance Committee to Oppose HB 246
HB 246 would impose onerous regulations on pharmacy benefit managers.
CCAGW Urges Minnesota House of Representatives to Remove Prescription Drug Affordability Board Provisions From SF 2744
Price controls distort markets, hurt innovation, and exacerbate the problems they are created to fix.
CCAGW Urges Louisiana House of Representatives to Oppose HB548
HB548 will make changes to the federal 340B drug discount program.
CCAGW Urges Florida Senate Rules Committee to Oppose SB 262
SB 262 would harm consumers and small businesses.
CCAGW Urges Minnesota Senate to Remove Prescription Drug Affordability Board Provisions From SF 2744
Price controls distort markets, hurt innovation, and exacerbate the problems they are created to fix.
CCAGW Urges Florida Senate Fiscal Policy Committee to Oppose SB 1550
SB 1550 will damage the private sector healthcare market and government healthcare plans.
CCAGW Urges Missouri Senate Economic Development and Tax Policy Committee to Support HB 268
HB 268 will allow for greater innovation and competition in Missouri by establishing a regulatory sandbox.
CCAGW Urges Florida Legislature to Oppose HB 1547 and SB 262
HB 1547 and SB 262 would harm consumers and small businesses.
